Treatment of graves disease
Pro Research Analysisby 
Searched over 200M research papers
Treatment of Graves' Disease: An Overview
Graves' disease is an autoimmune disorder that is the most common cause of hyperthyroidism. It is characterized by the production of thyroid-stimulating autoantibodies that target the thyrotropin receptor on thyroid cells, leading to excessive thyroid hormone production. The treatment of Graves' disease involves several options, each with its own benefits and risks.
Antithyroid Drugs (ATDs)
Methimazole and Propylthiouracil
Antithyroid drugs (ATDs) such as methimazole (MMI) and propylthiouracil (PTU) are commonly used to manage Graves' disease. MMI is often preferred due to its longer half-life, which allows for once-daily dosing and better patient adherence . PTU is typically reserved for pregnant and breastfeeding women because it has limited transfer into the placenta and breast milk Streetman2003Kahaly2018. However, long-term remission rates with ATDs are generally low, and there is a risk of serious adverse reactions such as agranulocytosis and hepatotoxicity Burch2015Starling2019.
Radioactive Iodine (RAI) Therapy
RAI therapy is a widely used treatment for Graves' disease, particularly in the United States. It is effective, easy to administer, and more affordable than long-term ATD treatment . However, RAI therapy often leads to hypothyroidism, necessitating lifelong levothyroxine replacement . Additionally, RAI is contraindicated in pregnant women and those with severe Graves' orbitopathy due to the risk of worsening eye disease Streetman2003Kahaly2018.
Surgical Treatment
Total Thyroidectomy vs. Subtotal Thyroidectomy
Surgery is another definitive treatment option for Graves' disease, particularly for patients with large goiters, suspicious thyroid nodules, or significant ophthalmopathy Bobanga2019Stålberg2008. Total thyroidectomy is increasingly preferred over subtotal thyroidectomy due to its nearly 0% recurrence rate and predictable postoperative hypothyroidism Bobanga2019Stålberg2008Genovese2013. However, surgery carries risks such as hypoparathyroidism and vocal cord paralysis, which are minimized when performed by experienced surgeons Burch2015Kahaly2018.
Treatment in Special Populations
Children
In pediatric patients, the management of Graves' disease remains controversial. ATDs are often the first line of treatment, but they have low long-term remission rates and potential adverse effects De Luca2018Rivkees2006. Definitive treatments such as RAI or surgery are often necessary, with surgery being preferred in very young children due to concerns about the long-term safety of RAI Stålberg2008Rivkees2006.
Pregnant Women
For pregnant women, PTU is the preferred ATD due to its safety profile during pregnancy Streetman2003Kahaly2018. Some women may opt for definitive treatment with RAI or surgery before pregnancy to avoid the teratogenic effects of ATDs .
Conclusion
The treatment of Graves' disease involves a choice between antithyroid drugs, radioactive iodine therapy, and surgery. Each option has its own set of benefits and risks, and the optimal approach depends on individual patient factors such as age, pregnancy status, the presence of ophthalmopathy, and patient preference. Physicians must be well-versed in the advantages and disadvantages of each treatment to provide the best possible care for their patients.
Sources and full results
Most relevant research papers on this topic